CATX
CATX
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
3
$67K
Insider Sales
0
$0
Total Volume
$67K
13 transactions
Net Activity
+$67K
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Minor cluster buying: 2 unique insiders purchased shares.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale Insiders
$11.94B total
Puhlmann Markus
Chief Medical Officer
$35K total
Williamson Robert F III
Dir
$33K total
Quick Actions
CATX has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. CATX ranks #490 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at CATX (CATX) engaged in a total of 13 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 0 were sales. The total volume of insider trading reached $67K.
The net insider activity for CATX shows a net buying bias of $67K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 188.3K shares valued at $4.42B on Mar 31, 2025.
At $0.80 a share, the RFW3 Revocable Trust bought 15,000 shares of Perspective Therapeutics (CATX).
Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year?
Perspective Therapeutics director buys $12,000 in company stock By Investing.com
$CATX Stock Is Down 27% Today. Here's What We See in Our Data.
CATX - Perspective Therapeutics Inc Stock Price and Quote
$CATX stock is down 10% today. Here's what we see in our data.
FAQs About CATX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for CATX.